Partner Headlines - SLXP

  1. Benzinga's M&A Chatter for Tuesday January 20, 2015

    Benzinga
  2. Salix Pharmaceuticals

    IBD
  3. Report: Salix Pharmaceuticals Exploring Possible Sale

    Benzinga
  4. Salix Pharma Reportedly Exploring Sale; Stock Up

    IBD
  5. Jefferies Weighs In On Specialty Pharmaceuticals After Management ...

    Benzinga
  6. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  7. Stocks Mixed As Early Strength Fades; Salix Jumps

    IBD
  8. SALIX

    IBD
  9. Benzinga's M&A Chatter for Thursday December 18, 2014

    Benzinga
  10. Credit Suisse Raises Salix Pharmaceuticals Price Target

    Benzinga
  11. Salix rebounding from crash

    IBD
  12. Salix Destocking Plan, 2-Year Guidance Soothe Street

    IBD
  13. #PreMarket Movers From December 16, 2014

    Benzinga
  14. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus
  15. Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are ...

    Benzinga
  16. How Adam Feuerstein Follows The Biotech Sector

    Benzinga
  17. Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

    Benzinga
  18. U.S. Produced Fewer Than Expected Jobs In October

    Benzinga
  19. Health Sell-Offs Drag On IBD 50

    IBD
  20. Dow, S&P 500 Flirt With Record, But Finish Just Off

    IBD
  21. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  22. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  23. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  24. Mid-Day Market Update: Allscripts Healthcare Slides On Downbeat ...

    Benzinga
  25. Mid-Morning Market Update: Markets Edge Lower; Humana Profit ...

    Benzinga
  26. Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being ...

    Benzinga
  27. Morning Market Losers

    Benzinga
  28. Benzinga's Top Downgrades

    Benzinga
  29. Stocks Set For Higher Start After Mixed Jobs Report

    IBD
  30. Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold

    Benzinga
  31. Benzinga's Top #PreMarket Losers

    Benzinga
  32. UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered ...

    Benzinga
  33. Salix Dives On Earnings, Probe; Akorn A Bad Seed Too

    IBD
  34. Salix Dives On Miss, Probe

    IBD
  35. Indexes Higher; El Pollo Loco Reports In Line

    IBD
  36. Stocks Cling To Modest Gains; Advance Auto Rebounds

    IBD
  37. Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars

    IBD
  38. Earnings Scheduled For November 6, 2014

    Benzinga
  39. 3 IBD 50 Tech, Drug Stocks With Earnings Thursday

    IBD
  40. Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap

    IBD
  41. Salix, Skyworks Lead 6 IBD 50 Earnings Reports On Tap

    IBD
  42. Stocks Hold Near Session Highs; Drugmakers Shine Again

    IBD
  43. Making Money With Charles Payne: 10/17/14

    FoxBusiness
  44. Will Activis Win Competition For Allergan's Affection?

    Benzinga
  45. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD
  46. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD
  47. Stocks Dive, Then Pare Losses; Shire, Expedia, KeyCorp Crumble

    IBD
  48. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD
  49. Patents, Taxes Lift Drug M&A

    IBD
  50. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD
  51. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD
  52. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD
  53. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD
  54. Salix Pharmaceuticals

    IBD
  55. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD
  56. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR ...

    Benzinga
  57. Stocks Further Deteriorate; Salix Breaks Support

    IBD
  58. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD
  59. Salix Bails On Tax Inversion

    IBD
  60. Nasdaq, S&P 500 Aim For 50-Day Lines; Alexion Breaks Out

    IBD
  61. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD
  62. Stocks Open Higher On Jobs Data; Mylan, Salix, Mobileye Climb

    IBD
  63. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  64. SALIX PHARMACEUTICALS

    IBD
  65. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD
  66. Stifel Raises Price Target On Salix Pharmaceuticals, Ltd. On ...

    Benzinga
  67. Morning Market Losers

    Benzinga
  68. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD
  69. Stocks Fade More In Late Trade; GoPro Hangs Tough

    IBD
  70. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD
  71. Jackson Square Partners Joins Investors Opposing Allergan Bid ...

    Benzinga
  72. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD
  73. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD
  74. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD
  75. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD
  76. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga
  77. Pharma Buyout Bids Beat On

    IBD
  78. Facebook, Three Other Leaders In Striking Distance

    IBD
  79. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD
  80. #PreMarket Primer: Wednesday, September 24: US Economy Looking ...

    Benzinga
  81. Ackman forewarns Allergan

    IBD
  82. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga
  83. Stocks Finish Lower Among Takeover Rumors

    IBD
  84. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga
  85. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD
  86. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares ...

    Benzinga
  87. Stocks Fall Modestly; New Issue Alibaba Extends Losses

    IBD
  88. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD
  89. Markets Mixed; Carnival Profit Tops Street View

    Benzinga
  90. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD
  91. Benzinga's Volume Movers

    Benzinga
  92. Stocks Hitting 52-Week Highs

    Benzinga
  93. Morning Market Movers

    Benzinga
  94. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD
  95. Benzinga's Top #PreMarket Gainers

    Benzinga
  96. #PreMarket Primer: Tuesday, September 23: First Airstrikes In ...

    Benzinga
  97. US Stock Futures Fall Ahead Of Economic Data

    Benzinga
  98. Stocks To Watch For September 23, 2014

    Benzinga
  99. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga
  100. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga
Trading Center